287 related articles for article (PubMed ID: 29222300)
21. Understanding biology to tackle the disease: Multiple myeloma from bench to bedside, and back.
Bianchi G; Anderson KC
CA Cancer J Clin; 2014; 64(6):422-44. PubMed ID: 25266555
[TBL] [Abstract][Full Text] [Related]
22. Emerging biological insights and novel treatment strategies in multiple myeloma.
Gentile M; Recchia AG; Mazzone C; Morabito F
Expert Opin Emerg Drugs; 2012 Sep; 17(3):407-38. PubMed ID: 22920042
[TBL] [Abstract][Full Text] [Related]
23. Clinical and Pharmacologic Features of Monoclonal Antibodies and Checkpoint Blockade Therapy in Multiple Myeloma.
D'Agostino M; Gazzera G; Cetani G; Bringhen S; Boccadoro M; Gay F
Curr Med Chem; 2019; 26(32):5968-5981. PubMed ID: 29756564
[TBL] [Abstract][Full Text] [Related]
24. Common Adverse Effects of Novel Therapies for Multiple Myeloma (MM) and Their Management Strategies.
McCullough KB; Hobbs MA; Abeykoon JP; Kapoor P
Curr Hematol Malig Rep; 2018 Apr; 13(2):114-124. PubMed ID: 29450683
[TBL] [Abstract][Full Text] [Related]
25. Role of Immunotherapy in Targeting the Bone Marrow Microenvironment in Multiple Myeloma: An Evolving Therapeutic Strategy.
Chung C
Pharmacotherapy; 2017 Jan; 37(1):129-143. PubMed ID: 27870103
[TBL] [Abstract][Full Text] [Related]
26. Multiple myeloma.
Röllig C; Knop S; Bornhäuser M
Lancet; 2015 May; 385(9983):2197-208. PubMed ID: 25540889
[TBL] [Abstract][Full Text] [Related]
27. A question of class: Treatment options for patients with relapsed and/or refractory multiple myeloma.
Cook G; Zweegman S; Mateos MV; Suzan F; Moreau P
Crit Rev Oncol Hematol; 2018 Jan; 121():74-89. PubMed ID: 29279102
[TBL] [Abstract][Full Text] [Related]
28. The Tao of myeloma.
Boise LH; Kaufman JL; Bahlis NJ; Lonial S; Lee KP
Blood; 2014 Sep; 124(12):1873-9. PubMed ID: 25097176
[TBL] [Abstract][Full Text] [Related]
29. Emerging therapies targeting the ubiquitin proteasome system in cancer.
Weathington NM; Mallampalli RK
J Clin Invest; 2014 Jan; 124(1):6-12. PubMed ID: 24382383
[TBL] [Abstract][Full Text] [Related]
30. Advances in targeted therapy for the treatment of patients with relapsed/refractory multiple myeloma.
Le Ray E; Jagannath S; Palumbo A
Expert Rev Hematol; 2016 Jan; 9(1):91-105. PubMed ID: 26558304
[TBL] [Abstract][Full Text] [Related]
31. [Diagnostic and therapeutic considerations on recurrence of multiple myeloma : A current overview].
Kortüm KM; Einsele H
Internist (Berl); 2019 Jan; 60(1):34-41. PubMed ID: 30536028
[TBL] [Abstract][Full Text] [Related]
32. Update on PD-1/PD-L1 Inhibitors in Multiple Myeloma.
Jelinek T; Paiva B; Hajek R
Front Immunol; 2018; 9():2431. PubMed ID: 30505301
[TBL] [Abstract][Full Text] [Related]
33. Multiple myeloma: Updates for pharmacists in the treatment of relapsed and refractory disease.
Ashjian E; Redic K
J Oncol Pharm Pract; 2016 Apr; 22(2):289-302. PubMed ID: 25694345
[TBL] [Abstract][Full Text] [Related]
34. [Multiple myeloma: pathophysiology and progress in management].
Kuroda J; Chinen Y
Rinsho Ketsueki; 2017; 58(5):487-497. PubMed ID: 28592764
[TBL] [Abstract][Full Text] [Related]
35. Seeking Convergence and Cure with New Myeloma Therapies.
Choudhry P; Galligan D; Wiita AP
Trends Cancer; 2018 Aug; 4(8):567-582. PubMed ID: 30064664
[TBL] [Abstract][Full Text] [Related]
36. Monoclonal antibodies in the treatment of multiple myeloma: current status and future perspectives.
Lonial S; Durie B; Palumbo A; San-Miguel J
Leukemia; 2016 Mar; 30(3):526-35. PubMed ID: 26265184
[TBL] [Abstract][Full Text] [Related]
37. Emerging therapies for relapsed/refractory multiple myeloma: CAR-T and beyond.
Su CT; Ye JC
J Hematol Oncol; 2021 Jul; 14(1):115. PubMed ID: 34301270
[TBL] [Abstract][Full Text] [Related]
38. [Novel targeted therapy in multiple myeloma].
Izumi T
Nihon Rinsho; 2014 Jun; 72(6):1089-93. PubMed ID: 25016809
[TBL] [Abstract][Full Text] [Related]
39. Targeting BCMA in Multiple Myeloma.
Tan CR; Shah UA
Curr Hematol Malig Rep; 2021 Oct; 16(5):367-383. PubMed ID: 34432234
[TBL] [Abstract][Full Text] [Related]
40. Kidney Transplant in the Era of Modern Therapy for Multiple Myeloma.
Huskey JL; Heilman RL; Khamash H; Fonseca R
Transplantation; 2018 Dec; 102(12):1994-2001. PubMed ID: 30211830
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]